©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 110143
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110143
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110143
Table 5 Medication use and treatment compliance analysis, mean ± SD
| Characteristic | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Postoperative analgesic use (days) | 6.2 ± 2.1 | 3.8 ± 1.2 | t = 2.74 | < 0.001 |
| Antibiotic use duration (days) | 7.3 ± 2.4 | 4.1 ± 1.5 | t = 2.89 | < 0.001 |
| Treatment compliance rate | 0.903 (56/62) | 0.971 (68/70) | χ² = 1.98 | 0.048 |
| Total medication cost (dollars) | 286.4 ± 54.7 | 198.3 ± 41.2 | t = 2.56 | < 0.001 |
| Medication-related adverse events | 0.161 (10/62) | 0.071 (5/70) | χ² = 2.23 | 0.026 |
| Patient-reported medication satisfaction (0-10) | 6.8 ± 1.4 | 8.2 ± 1.1 | t = 2.41 | < 0.001 |
| Medication dose adjustment times | 2.7 ± 1.3 | 1.4 ± 0.8 | t = 2.18 | 0.003 |
- Citation: Liu JF, Wang Y, Peng XS, Li QL. Enhanced surgical management of complex anal fistulas via integrated traditional Chinese medicine: A retrospective cohort study. World J Gastrointest Surg 2025; 17(11): 110143
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/110143.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.110143